de Northern Trust Acadia Pharmaceuticals ACAD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 34.6 M | Comprar |
1,367,422
+94,811
| +7% | +USD 2.09 M | ﹤0.01% | 1454 |
|
|
2026
Q1 | USD 28.3 M | Comprar |
1,272,611
+36,782
| +3% | +USD 879 k | ﹤0.01% | 1464 |
|
|
2025
Q4 | USD 33 M | Vender |
1,235,829
-67,707
| -5% | -USD 1.62 M | ﹤0.01% | 1368 |
|
|
2025
Q3 | USD 27.8 M | Comprar |
1,303,536
+920
| +0.1% | +USD 21.8 k | ﹤0.01% | 1482 |
|
|
2025
Q2 | USD 28.1 M | Vender |
1,302,616
-72,597
| -5% | -USD 1.35 M | ﹤0.01% | 1444 |
|
|
2025
Q1 | USD 22.8 M | Comprar |
1,375,213
+142,847
| +12% | +USD 2.6 M | ﹤0.01% | 1554 |
|
|
2024
Q4 | USD 22.6 M | Comprar |
1,232,366
+106,236
| +9% | +USD 1.71 M | ﹤0.01% | 1615 |
|
|
2024
Q3 | USD 17.3 M | Vender |
1,126,130
-18,628
| -2% | -USD 311 k | ﹤0.01% | 1706 |
|
|
2024
Q2 | USD 18.6 M | Vender |
1,144,758
-47,068
| -4% | -USD 760 k | ﹤0.01% | 1597 |
|
|
2024
Q1 | USD 22 M | Vender |
1,191,826
-22,307
| -2% | -USD 553 k | ﹤0.01% | 1526 |
|
|
2023
Q4 | USD 38 M | Vender |
1,214,133
-6,544
| -0.5% | -USD 156 k | 0.01% | 1199 |
|
|
2023
Q3 | USD 25.4 M | Comprar |
1,220,677
+57,555
| +5% | +USD 1.56 M | ﹤0.01% | 1391 |
|
|
2023
Q2 | USD 27.9 M | Vender |
1,163,122
-3,602
| -0.3% | -USD 80.1 k | 0.01% | 1372 |
|
|
2023
Q1 | USD 22 M | Comprar |
1,166,724
+39,440
| +3% | +USD 751 k | ﹤0.01% | 1499 |
|
|
2022
Q4 | USD 17.9 M | Comprar |
1,127,284
+10,345
| +0.9% | +USD 162 k | ﹤0.01% | 1608 |
|
|
2022
Q3 | USD 18.3 M | Vender |
1,116,939
-13,848
| -1% | -USD 224 k | ﹤0.01% | 1547 |
|
|
2022
Q2 | USD 15.9 M | Vender |
1,130,787
-39,779
| -3% | -USD 742 k | ﹤0.01% | 1696 |
|
|
2022
Q1 | USD 28.4 M | Vender |
1,170,566
-54,096
| -4% | -USD 1.31 M | 0.01% | 1427 |
|
|
2021
Q4 | USD 28.6 M | Vender |
1,224,662
-74,657
| -6% | -USD 1.5 M | ﹤0.01% | 1518 |
|
|
2021
Q3 | USD 21.6 M | Vender |
1,299,319
-40,331
| -3% | -USD 777 k | ﹤0.01% | 1755 |
|
|
2021
Q2 | USD 32.7 M | Comprar |
1,339,650
+733,652
| +121% | +USD 16.6 M | 0.01% | 1525 |
|
|
2021
Q1 | USD 15.6 M | Comprar |
605,998
+8,625
| +1% | +USD 380 k | ﹤0.01% | 2001 |
|
|
2020
Q4 | USD 31.9 M | Comprar |
597,373
+9,490
| +2% | +USD 471 k | 0.01% | 1440 |
|
|
2020
Q3 | USD 24.2 M | Vender |
587,883
-16,917
| -3% | -USD 731 k | 0.01% | 1481 |
|
|
2020
Q2 | USD 29.3 M | Vender |
604,800
-892,709
| -60% | -USD 42.9 M | 0.01% | 1314 |
|
|
2020
Q1 | USD 63.3 M | Comprar |
1,497,509
+21,989
| +1% | +USD 906 k | 0.02% | 653 |
|
|
2019
Q4 | USD 63.1 M | Comprar |
1,475,520
+54,925
| +4% | +USD 2.39 M | 0.01% | 846 |
|
|
2019
Q3 | USD 51.1 M | Vender |
1,420,595
-48,189
| -3% | -USD 1.46 M | 0.01% | 957 |
|
|
2019
Q2 | USD 39.3 M | Vender |
1,468,784
-17,862
| -1% | -USD 456 k | 0.01% | 1188 |
|
|
2019
Q1 | USD 39.9 M | Comprar |
1,486,646
+143,297
| +11% | +USD 3.35 M | 0.01% | 1148 |
|
|
2018
Q4 | USD 21.7 M | Comprar |
1,343,349
+56,449
| +4% | +USD 1.1 M | 0.01% | 1514 |
|
|
2018
Q3 | USD 26.7 M | Comprar |
1,286,900
+25,365
| +2% | +USD 399 k | 0.01% | 1543 |
|
|
2018
Q2 | USD 19.3 M | Comprar |
1,261,535
+771,631
| +158% | +USD 13.8 M | ﹤0.01% | 1807 |
|
|
2018
Q1 | USD 11 M | Comprar |
489,904
+17,680
| +4% | +USD 489 k | ﹤0.01% | 2108 |
|
|
2017
Q4 | USD 14.2 M | Comprar |
472,224
+691
| +0.1% | +USD 22.1 k | ﹤0.01% | 1957 |
|
|
2017
Q3 | USD 17.8 M | Comprar |
471,533
+2,090
| +0.4% | +USD 68 k | ﹤0.01% | 1791 |
|
|
2017
Q2 | USD 13.1 M | Vender |
469,443
-4,885
| -1% | -USD 146 k | ﹤0.01% | 1988 |
|
|
2017
Q1 | USD 16.3 M | Comprar |
474,328
+11,862
| +3% | +USD 419 k | ﹤0.01% | 1779 |
|
|
2016
Q4 | USD 13.3 M | Comprar |
462,466
+26,318
| +6% | +USD 696 k | ﹤0.01% | 1896 |
|
|
2016
Q3 | USD 13.9 M | Comprar |
436,148
+27,821
| +7% | +USD 943 k | ﹤0.01% | 1848 |
|
|
2016
Q2 | USD 13.3 M | Vender |
408,327
-576,878
| -59% | -USD 19.3 M | ﹤0.01% | 1827 |
|
|
2016
Q1 | USD 27.7 M | Comprar |
985,205
+68,501
| +7% | +USD 1.49 M | 0.01% | 1227 |
|
|
2015
Q4 | USD 32.7 M | Comprar |
916,704
+17,599
| +2% | +USD 620 k | 0.01% | 1104 |
|
|
2015
Q3 | USD 29.7 M | Comprar |
899,105
+15,453
| +2% | +USD 643 k | 0.01% | 1190 |
|
|
2015
Q2 | USD 37 M | Vender |
883,652
-12,158
| -1% | -USD 471 k | 0.01% | 1090 |
|
|
2015
Q1 | USD 29.2 M | Comprar |
895,810
+14,225
| +2% | +USD 489 k | 0.01% | 1285 |
|
|
2014
Q4 | USD 28 M | Vender |
881,585
-24,565
| -3% | -USD 697 k | 0.01% | 1282 |
|
|
2014
Q3 | USD 22.4 M | Vender |
906,150
-29,343
| -3% | -USD 686 k | 0.01% | 1416 |
|
|
2014
Q2 | USD 21.1 M | Vender |
935,493
-26,063
| -3% | -USD 544 k | 0.01% | 1472 |
|
|
2014
Q1 | USD 23.4 M | Vender |
961,556
-36,174
| -4% | -USD 915 k | 0.01% | 1452 |
|
|
2013
Q4 | USD 24.9 M | Vender |
997,730
-45,949
| -4% | -USD 1.08 M | 0.01% | 1342 |
|
|
2013
Q3 | USD 28.7 M | Comprar |
1,043,679
+569,512
| +120% | +USD 11.9 M | 0.01% | 1147 |
|
|
2013
Q2 | USD 8.61 M | Comprar |
+474,167
| Nuevas | +USD 6.53 M | ﹤0.01% | 2029 |
|
Otros fondos que tienen ACAD en su cartera
BBA
Posición de Northern Trust en ACAD: resumen de T2 2026
Northern Trust aumentó su participación en Acadia Pharmaceuticals (ACAD) en 7.5% durante T2 2026, al comprar aproximadamente USD 2.09 M y elevar la posición a 1,367,422 acciones con un valor de USD 34.6 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1454.
Northern Trust reportó por primera vez una posición en ACAD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 63.3 M en T1 2020. Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank mantienen una posición en ACAD.
- Al cierre de T2 2026, Northern Trust tenía 1,367,422 acciones de Acadia Pharmaceuticals con un valor de USD 34.6 M.
- Northern Trust compró 94,811 acciones de Acadia Pharmaceuticals en T2 2026, por un monto estimado de USD 2.09 M.
- Acadia Pharmaceuticals representó ﹤0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 1454.
- Northern Trust reportó por primera vez una posición en Acadia Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en Acadia Pharmaceuticals alcanzó su máximo de USD 63.3 M en T1 2020.
- Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank tenían Acadia Pharmaceuticals en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.